- Home
- CLDI vs EQS Comparison
CLDI vs EQS Comparison
Compare CLDI & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- EQS
- Stock Information
- Founded
- CLDI 2014
- EQS 1991
- Country
- CLDI United States
- EQS United States
- Employees
- CLDI N/A
- EQS N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- EQS Finance Companies
- Sector
- CLDI Health Care
- EQS Finance
- Exchange
- CLDI Nasdaq
- EQS Nasdaq
- Market Cap
- CLDI 18.1M
- EQS 14.9M
- IPO Year
- CLDI N/A
- EQS N/A
- Fundamental
- Price
- CLDI $1.36
- EQS $1.06
- Analyst Decision
- CLDI Strong Buy
- EQS
- Analyst Count
- CLDI 3
- EQS 0
- Target Price
- CLDI $16.67
- EQS N/A
- AVG Volume (30 Days)
- CLDI 1.1M
- EQS 13.2K
- Earning Date
- CLDI 11-12-2024
- EQS 01-01-0001
- Dividend Yield
- CLDI N/A
- EQS N/A
- EPS Growth
- CLDI N/A
- EQS N/A
- EPS
- CLDI N/A
- EQS N/A
- Revenue
- CLDI N/A
- EQS $1,137,000.00
- Revenue This Year
- CLDI N/A
- EQS N/A
- Revenue Next Year
- CLDI N/A
- EQS N/A
- P/E Ratio
- CLDI N/A
- EQS N/A
- Revenue Growth
- CLDI N/A
- EQS 1795.00
- 52 Week Low
- CLDI $0.14
- EQS $1.01
- 52 Week High
- CLDI $3.89
- EQS $1.95
- Technical
- Relative Strength Index (RSI)
- CLDI 35.60
- EQS 32.54
- Support Level
- CLDI $1.60
- EQS $1.01
- Resistance Level
- CLDI $2.17
- EQS $1.24
- Average True Range (ATR)
- CLDI 0.20
- EQS 0.09
- MACD
- CLDI -0.10
- EQS -0.00
- Stochastic Oscillator
- CLDI 10.00
- EQS 15.62
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.